FDA Approves FoundationOne®Liquid CDx for TEPMETKO® in NSCLC Cancer
18 Nov 2024 //
BUSINESSWIRE
FDA Approves FoundationOne CDx as Companion Diagnostics for Lynparza
03 Sep 2024 //
BUSINESSWIRE
FDA Approves FoundationOne Liquid CDx As Companion Diagnostic For AKEEGA
01 Jul 2024 //
BUSINESSWIRE
ELRIG UK establishes Scientific Advisory Board
17 Mar 2022 //
BUSINESSWIRE